During the past decade, Group Health Central Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 43 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Group Health Central Hospital" #1 sponsor was "SWOG Cancer Research Network" with 78 trials, followed by "Children's Oncology Group" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Group Health Central Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 113 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 11 trials as a collaborator, "Eastern Cooperative Oncology Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Group Health Central Hospital" are "Breast Cancer" (20 trials), "Lung Cancer" (16 trials), "Lymphoma" (15 trials), "Leukemia" (14 trials) and "Sarcoma" (7 trials). Many other conditions were trialed in "Group Health Central Hospital" in a lesser frequency.

Most popular intervention types in "Group Health Central Hospital" are "Drug" (91 trials), "Biological" (35 trials), "Radiation" (26 trials), "Other" (24 trials) and "Procedure" (20 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (24 trials), "radiation therapy" (18 trials), "doxorubicin hydrochloride" (15 trials), "filgrastim" (13 trials) and "cisplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "Group Health Central Hospital" are 93 trials for "All" genders, 19 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Group Health Central Hospital". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 95 completed trials in Group Health Central Hospital, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Group Health Central Hospital, 3 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".